Healthpeak Properties, Inc.
19.25USD
-0.0900 (-0.47%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on DOC.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.03▲ | $0 | 0 | 0 |
| Next quarter | $0.03▲ | $0 | 0 | 0 |
| Current year | $0.09▲ | $0 | 0 | 1 |
| Next year | $0.14▲ | -$0.15 | 0 | 1 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.03 | $0.08 | +0.05 (+198.6%) |
| 2026-03-31 | $0.06 | $0.28 | +0.22 (+364.7%) |
| 2025-12-31 | $0.06 | $0.1 | +0.04 (+59.3%) |
| 2025-09-30 | $0.06 | -$0.18 | -0.24 (-403.2%) |
124 ratings from 25 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wells Fargo | Maintained | Equal-Weight | $22 $19 | Oct 19, 2026 |
| UBS | Maintained | Neutral | $21.5 $20 | Oct 13, 2026 |
| Barclays | Maintained | Equal-Weight | $24 $21 | Oct 13, 2026 |
| Evercore ISI Group | Maintained | In-Line | $23 $22 | Sep 21, 2026 |
| Barclays | Maintained | Equal-Weight | $23 $24 | Aug 31, 2026 |
| Baird | Maintained | Outperform | $21 $24 | Aug 13, 2026 |
| Citigroup | Maintained | Neutral | $20 $22 | Aug 11, 2026 |
| RBC Capital | Maintained | Outperform | $21 $24 | Aug 10, 2026 |
| Cantor Fitzgerald | Maintained | Neutral | $20 $23 | Aug 6, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $20 $22 | Jul 15, 2026 |
| UBS | Maintained | Neutral | $19 $21.5 | Jul 8, 2026 |
| Barclays | Initiated from Overweight | Equal-Weight | $23 | Jul 7, 2026 |
| Mizuho | Maintained | Outperform | $21 $24 | Jul 6, 2026 |
| JP Morgan | Maintained | Neutral | $18 $21 | Jun 24, 2026 |
| BMO Capital | Maintained | Outperform | $20 $24 | Jun 15, 2026 |
| Morgan Stanley | Downgraded from Overweight | Equal-Weight | $20 $22 | Jun 11, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $18 $20 | Jun 1, 2026 |
| Scotiabank | Maintained | Sector Perform | $19 $21 | May 27, 2026 |
| Morgan Stanley | Maintained | Overweight | $18 $20 | May 22, 2026 |
| RBC Capital | Maintained | Outperform | $20 $21 | May 14, 2026 |
| UBS | Maintained | Neutral | $17 $19 | May 13, 2026 |
| Baird | Maintained | Outperform | $19 $21 | May 13, 2026 |
| Citigroup | Maintained | Neutral | $17.5 $20 | May 12, 2026 |
| Morgan Stanley | Maintained | Overweight | $21 $18 | Apr 28, 2026 |
| UBS | Initiated | Neutral | $17 | Apr 20, 2026 |
50 filings from 18 insiders · 13 buy / 1 sell over 6m
Officers and directors of DOC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| JOHNSTON SHAWN GOfficer | Grant | 1.4k | $15.46 | $21k | May 29, 2026 |
| BRINKER SCOTT MChief Executive Officer | Grant | 1.3k | $15.46 | $21k | May 29, 2026 |
| THOMAS JOHN TDirector | Grant | 1.4k | $15.46 | $21k | May 29, 2026 |
| MOSES KELVIN OChief Financial Officer | Grant | 937 | $15.46 | $14k | May 29, 2026 |
| PATADIA ANKIT BOfficer and Treasurer | Grant | 1.4k | $15.46 | $21k | May 29, 2026 |
| MABRY ADAM GChief Investment Officer | Grant | 625 | $15.46 | $10k | May 29, 2026 |
| BOHN SCOTT ROfficer | Sell | 11.0k | $19.45 | $214k | May 12, 2026 |
| GRIFFIN R KENT JRDirector | Grant | 9.7k | — | — | May 6, 2026 |
| CONNOR JAMES BDirector | Grant | 9.7k | — | — | May 6, 2026 |
| SANDSTROM KATHERINE MDirector | Grant | 9.7k | — | — | May 6, 2026 |
| WEISS RICHARD ADirector | Grant | 9.7k | — | — | May 6, 2026 |
| CARTWRIGHT BRIAN G.Director | Grant | 9.7k | — | — | May 6, 2026 |
| LIAS-BOOKER AVA E.Director | Grant | 9.7k | — | — | May 6, 2026 |
| LEWIS SARA GROOTWASSINKDirector | Grant | 9.7k | — | — | May 6, 2026 |
| THOMAS JOHN TDirector | Grant | 23.7k | — | — | Feb 6, 2026 |
| ALONSO LISA AOfficer | Grant | 4.3k | — | — | Jan 28, 2026 |
| JOHNSTON SHAWN GOfficer | Grant | 1.7k | $14.80 | $25k | Nov 28, 2025 |
| BRINKER SCOTT MChief Executive Officer | Grant | 1.7k | $14.80 | $25k | Nov 28, 2025 |
| THOMAS JOHN TDirector | Grant | 1.4k | $14.80 | $21k | Nov 28, 2025 |
| MOSES KELVIN OChief Financial Officer | Grant | 810 | $14.80 | $12k | Nov 28, 2025 |
No analyst notes on DOC yet.
Analyst Ratings
19 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 6 | 14 | 0 | 0 | Hold2.55 |
| 1 mo ago | 3 | 5 | 14 | 0 | 0 | Hold2.50 |
| 2 mo ago | 3 | 5 | 14 | 0 | 0 | Hold2.50 |
| 3 mo ago | 3 | 5 | 14 | 0 | 0 | Hold2.50 |
Members whose judged calls on DOC have played out most reliably.
No settled calls on DOC yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice